gemcitabine hydrochloride [clinicaltrials_resource:7ad834d04d16e4c2f305a5ca9862048e]
intervention [clinicaltrials_vocabulary:intervention]
gemcitabine hydrochloride [clinicaltrials_resource:7ad834d04d16e4c2f305a5ca9862048e]
Bio2RDF identifier
7ad834d04d16e4c2f305a5ca9862048e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7ad834d04d16e4c2f305a5ca9862048e
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Days 1 and 8 of Cycles 1, 2 and 3 - 30 minute IV, 1000 mg/m2.
intervention name [clinicaltrials_vocabulary:intervention-name]
gemcitabine hydrochloride
other name [clinicaltrials_vocabulary:other-name]
identifier
clinicaltrials_resource:7ad834d04d16e4c2f305a5ca9862048e
title
gemcitabine hydrochloride
@en
type
label
gemcitabine hydrochloride [clinicaltrials_resource:7ad834d04d16e4c2f305a5ca9862048e]
@en